Poor prognosis associated with gain of chromosome 1Q21 in multiple myeloma may be overcome by treatment with a bortezomib combination

被引：0
|
作者：
Sagaster, V.
Odelga, V.
Kaufmann, H.
Ackermann, J.
Galhuber, M.
Zojer, N.
Ludwig, H.
Wieser, R.
Zielinski, C.
Drach, J.
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Wilhelminenspital Stadt Wien, Dept Med 1, Vienna, Austria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0405
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [21] The impact of Bortezomib-based induction on chromosome 1q21 gained newly diagnosed Multiple Myeloma of Chinese origin
    Tang, Hoi Ki Karen
    Fung, Chi Yeung
    Morgan, Gareth
    Siu, Lisa
    Ip, Ho Wan Alvin
    Yip, Sze Fai
    Lau, Ka Ngai Harry
    Wong, Howard
    Kho, Bonnie
    Lee, Harold
    Leung, Kwan Hung
    Lau, Chi Kuen
    Chim, Chor Sang
    Hwang, Yu Yan
    Sim, Joycelyn
    Ngai, Cheong
    Kwong, Yok Lam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S72 - S73
  • [22] ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
    Wu, Chuan
    Yang, Ting
    Liu, Yingmin
    Lu, Yicheng
    Yang, Yanping
    Liu, Xiaobo
    Liu, Xuelian
    Ye, Long
    Sun, Yue
    Wang, Xue
    Li, Qingchao
    Yang, Peiyu
    Yu, Xiaoyuan
    Gao, Sujun
    Kumar, Shaji
    Jin, Fengyan
    Dai, Yun
    Li, Wei
    CANCER MEDICINE, 2018, 7 (08): : 3899 - 3911
  • [23] Comparison of prognostic impact of chromosome 1Q21 gain in patients with multiple myelomatreated by bortezomib, thalidomide andany conventional therapy
    Nemec, P.
    Greslikova, H.
    Zaoralova, R.
    Filkova, H.
    Vranova, V.
    Kupska, R.
    Smejkalova, J.
    Oltova, A.
    Kuglik, P.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 49 - 49
  • [24] Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
    Nahi, Hareth
    Vatsveen, Thea Kristin
    Lund, Johan
    Heeg, Bart M. S.
    Preiss, Birgitte
    Alici, Evren
    Moller, Michael Boe
    Wader, Karin Fahl
    Moller, Hanne E. H.
    Groseth, Lill Anny
    Ostergaard, Brian
    Dai, Hong Yan
    Holmberg, Erik
    Gahrton, Gosta
    Waage, Anders
    Abildgaard, Niels
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 46 - 54
  • [25] Effect of amplification or gain of 1Q21 in patients with multiple myeloma treated with daratumumab
    Zamanillo, Irene
    Medina de Alba, Lucia
    Alonso, Rafael
    Maria Sanchez, Jose
    Cuellar, Clara
    Fernandez-Guijarro, Manuela
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S235 - S236
  • [26] 1q21 Gain May Challenge the Role of t(4;14) As an Adverse Prognostic Marker of Multiple Myeloma
    Du, Chenxing
    Gang, An
    Xu, Yan
    Mao, Xuehan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Li Zengjun
    Li, Chengwen
    Yi, Shuhua
    Hao, Mu
    Zou, Dehui
    Zhan, Fenghuang
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    Qiu, Lugui
    BLOOD, 2019, 134
  • [27] Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain
    Iriuchishima, Hirono
    Saito, Akio
    Mihara, Masahiro
    Terasaki, Yukie
    Matsumoto, Akira
    Isoda, Atsushi
    Furukawa, Yusuke
    Matsumoto, Morio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 71 - 79
  • [28] Impact of Gain 1q21 (1q21+) in Patients with multiple Myeloma and Translocation t(11;14)
    Udovica, S.
    Scherbler, W.
    Fritz, P.
    Schneller, A.
    Ludwig, H.
    Zojer, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 144 - 144
  • [29] Concomitant deletion of the short arm (Del 1p13.3) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
    Mohan, Meera
    Gong, Zimu
    Ashby, Timothy Cody
    Al Hadidi, Samer
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Alapat, Daisy
    Shaughnessy Jr, John D. D.
    Zhan, Fenghuang
    van Rhee, Frits
    Sawyer, Jeffery R.
    Tian, Erming
    Zangari, Maurizio
    CANCER, 2023, 129 (16) : 2491 - 2498
  • [30] Prognostic value of 1q21 amplification in multiple myeloma
    Abramova, T. V.
    Obukhova, T. N.
    Mendeleev, L. P.
    Pokrovskaya, O. S.
    Gribanova, E. O.
    Ryzhko, V. V.
    Grebenyuk, L. A.
    Nareyko, M. V.
    Solovyev, M. V.
    Votyakova, O. M.
    Kulikov, S. M.
    Rusinov, M. A.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07): : 32 - +
12345